RNA vs EGAN
Comparison between Atrium Therapeutics Inc (RNA, Company) and eGain Corp (EGAN, Company).
RNA is from the Healthcare sector, while EGAN is from the Technology sector.
RNA vs EGAN - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
Market Cap
Winner
RNA
$200M
EGAN
$199M
Max Drawdown
Winner
RNA
30.17%
EGAN
99.97%
Sharpe Ratio
RNA
-1.07
Winner
EGAN
0.60
5Y Beta
Winner
RNA
0.95
EGAN
1.20
Industry
RNA
Biotechnology
EGAN
Software - Application
P/E Ratio
RNA
N/A
EGAN
25.88
Forward P/E
RNA
N/A
EGAN
17.04
PEG Ratio
Winner
RNA
0.00
EGAN
0.29
5Y EPS CAGR
RNA
N/A
EGAN
2.46%
Debt to Equity
RNA
0.00%
EGAN
0.00%
Free Cash Flow Yield
RNA
0.00%
Winner
EGAN
6.86%
P/S Ratio
RNA
5.51
Winner
EGAN
2.16
P/B Ratio
Winner
RNA
0.86
EGAN
2.16
RNA vs EGAN - Historical Returns
Returns include dividend reinvestment.
1M
RNA
-5.86%
Winner
EGAN
+7.69%
3M
Winner
RNA
-14.92%
EGAN
-17.46%
6M
RNA
N/A
EGAN
-28.24%
1Y
RNA
N/A
EGAN
+21.44%
5Y(CAGR)
RNA
N/A
EGAN
-7.42%
10Y(CAGR)
RNA
N/A
EGAN
+8.41%
Max(CAGR)
RNA
-45.78%
Winner
EGAN
-12.78%
RNA vs EGAN - Annual Returns (1999 - 2026)
Returns include dividend reinvestment.
| Year | RNA | EGAN |
|---|---|---|
| 2026 | -16.14% | -28.10% |
| 2025 | N/A | +67.59% |
| 2024 | N/A | -24.39% |
| 2023 | N/A | -9.26% |
| 2022 | N/A | -9.97% |
| 2021 | N/A | -14.85% |
| 2020 | N/A | +46.16% |
| 2019 | N/A | +17.86% |
| 2018 | N/A | +20.55% |
| 2017 | N/A | +156.10% |
| 2016 | N/A | -48.28% |
| 2015 | N/A | -16.80% |
| 2014 | N/A | -49.36% |
| 2013 | N/A | +130.11% |
| 2012 | N/A | -36.62% |
| 2011 | N/A | +475.83% |
| 2010 | N/A | +29.81% |
| 2009 | N/A | +258.62% |
| 2008 | N/A | -58.33% |
| 2007 | N/A | -64.57% |
| 2006 | N/A | +81.94% |
| 2005 | N/A | -30.77% |
| 2004 | N/A | -53.95% |
| 2003 | N/A | -2.38% |
| 2002 | N/A | -86.27% |
| 2001 | N/A | -57.32% |
| 2000 | N/A | -91.51% |
| 1999 | N/A | +33.63% |
RNA vs EGAN Drawdown Comparison
The maximum drawdown for RNA was -30.17%, occurring on Jun 8, 2026. This drawdown has not yet recovered.
The maximum drawdown for EGAN was -99.97%, occurring on Jun 18, 2009. This drawdown has not yet recovered.
The current RNA drawdown is -25.21%. The current EGAN drawdown is -98.92%.
| Rank | RNA | EGAN |
|---|---|---|
| #1 | -30.17% Mar 4, 2026 - Jun 8, 2026 | -99.97% Mar 3, 2000 - Jun 18, 2009 |
| #2 | N/A | -53.68% Dec 8, 1999 - Mar 1, 2000 |
| #3 | N/A | -16.65% Nov 18, 1999 - Dec 2, 1999 |
| #4 | N/A | -14.29% Nov 8, 1999 - Nov 18, 1999 |
| #5 | N/A | -9.74% Nov 3, 1999 - Nov 8, 1999 |
| #6 | N/A | -6.18% Dec 2, 1999 - Dec 6, 1999 |
Correlation
Correlation between RNA and EGAN is 0.97 which considered as a very strong positive correlation - the stocks move almost identically together.
0.97
-101
Select Stocks to Compare
Popular: RNA vs SPYEGAN vs SPY
More Comparisons
Compare with similar stocks